Literature DB >> 12019343

Melatonin: reducing molecular pathology and dysfunction due to free radicals and associated reactants.

Russel J Reiter1, Duan-Xian Tan, Mario Allegra.   

Abstract

Endogenously produced metabolites of ground state oxygen are highly reactive and destructive to intracellular and extracellular molecules. The resulting damage, referred to as oxidative stress, leads to molecular and cellular dysfunction. The destruction of essential macromolecules by oxygen-based reactants is the basis of some diseases and is believed to be involved in the processes of aging. Free radical scavengers and antioxidants neutralize and/or metabolically remove reactive species from cells before they carry out their destructive activities. Melatonin is a highly ubiquitous direct free radical scavenger and indirect antioxidant. This brief report summarizes the interactions of melatonin with reactive species and identifies the resulting products. The paper also defines the melatonin antioxidant cascade wherein not only melatonin but at least one of the products, i.e., N(1)-acetyl-N(2)-formyl-5-methoxykynuramine, formed as a result of melatonin scavenging hydrogen peroxide is also a potent scavenger. The review summarizes the data which shows that melatonin is not only a pharmacologically useful free radical scavenger but that it functions in this capacity at physiological concentrations as well. Finally, this report identifies high oxidative stress situations in humans where melatonin has proven effective in reducing the severity of the disease state. In the last decade there have been hundreds of publications documenting melatonin's protective actions against a vast array of conditions, e.g., ischemia/reperfusion injury, toxin exposure, lipopolysaccharide exposure, etc., where free radical damage is a component of the condition.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12019343

Source DB:  PubMed          Journal:  Neuro Endocrinol Lett        ISSN: 0172-780X            Impact factor:   0.765


  15 in total

1.  Neuroprotective effects of ebselen on experimental spinal cord injury in rats.

Authors:  Murat Kalayci; Omer Coskun; Ferda Cagavi; Mehmet Kanter; Ferah Armutcu; Sanser Gul; Bektas Acikgoz
Journal:  Neurochem Res       Date:  2005-03       Impact factor: 3.996

Review 2.  Role of melatonin in neurodegenerative diseases.

Authors:  V Srinivasan; S R Pandi-Perumal; G Jm Maestroni; A I Esquifino; R Hardeland; D P Cardinali
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

Review 3.  [The influence of melatonin on hair physiology].

Authors:  T W Fischer
Journal:  Hautarzt       Date:  2009-12       Impact factor: 0.751

4.  Effects of melatonin administration on intestinal adaptive response after massive bowel resection in rats.

Authors:  Hulya Ozturk; Hayrettin Oztürk; Yusuf Yagmur; Ali Kemal Uzunlar
Journal:  Dig Dis Sci       Date:  2006-02       Impact factor: 3.199

5.  Antioxidative effect of melatonin, ascorbic acid and N-acetylcysteine on caerulein-induced pancreatitis and associated liver injury in rats.

Authors:  Mukaddes Eşrefoğlu; Mehmet Gül; Burhan Ates; Kadir Batçioğlu; Mukadder Ayşe Selimoğlu
Journal:  World J Gastroenterol       Date:  2006-01-14       Impact factor: 5.742

6.  Melatonin and vitamin C administration ameliorate diazepam-induced oxidative stress and cell proliferation in the liver of rats.

Authors:  G H El-Sokkary
Journal:  Cell Prolif       Date:  2008-02       Impact factor: 6.831

7.  Differential effects of vanadium, tungsten and molybdenum on inhibition of glucose formation in renal tubules and hepatocytes of control and diabetic rabbits: beneficial action of melatonin and N-acetylcysteine.

Authors:  A Kiersztan; K Winiarska; J Drozak; M Przedlacka; M Wegrzynowicz; T Fraczyk; J Bryla
Journal:  Mol Cell Biochem       Date:  2004-06       Impact factor: 3.396

8.  Diabetes-induced changes in glucose synthesis, intracellular glutathione status and hydroxyl free radical generation in rabbit kidney-cortex tubules.

Authors:  K Winiarska; J Drozak; M Wegrzynowicz; T Fraczyk; J Bryla
Journal:  Mol Cell Biochem       Date:  2004-06       Impact factor: 3.396

Review 9.  Melatonin: an established antioxidant worthy of use in clinical trials.

Authors:  Ahmet Korkmaz; Russel J Reiter; Turgut Topal; Lucien C Manchester; Sukru Oter; Dun-Xian Tan
Journal:  Mol Med       Date:  2008-11-04       Impact factor: 6.354

10.  Decreased daily melatonin levels in women with systemic lupus erythematosus - a short report.

Authors:  Ralitsa Robeva; Dobromir Tanev; Georgi Kirilov; Milena Stoycheva; Analia Tomova; Philip Kumanov; Rasho Rashkov; Zlatimir Kolarov
Journal:  Balkan Med J       Date:  2013-09-01       Impact factor: 2.021

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.